Rare diseases
Investigational molecules
Locations
Back to Poland1 013 clinical trials in Lodz, Poland across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of dapagliflozin effects in patients hospitalized with acute heart failure
PolandStudy Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
PolandStudy on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study
PolandStudy on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
PolandStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PolandStudy on the Safety and Effectiveness of Rozanolixizumab in Children with Generalized Myasthenia Gravis
PolandStudy on the Effects of Ozanimod for Children with Moderate to Severe Crohn's Disease Not Responding to Usual Treatments
PolandStudy on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid
PolandStudy on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery
PolandPolandStudy on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation
PolandPolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on respiratory viral infections and preventive vaccines, particularly targeting RSV and influenza in older adults. Studies evaluate vaccine efficacy and immune responses to protect against severe respiratory diseases.
Multiple studies assess combination vaccines and co-administration strategies to enhance protection against multiple respiratory pathogens.
Innovative research examining treatments for plaque psoriasis and related conditions. Trials investigate novel therapeutic approaches including oral medications and biological treatments for moderate to severe cases.
Studies focus on measuring improvement in disease severity and quality of life outcomes for patients.
Comprehensive research on meningococcal and pneumococcal vaccines, with special attention to pediatric populations. Studies evaluate safety profiles and immune responses across different age groups.
Trials incorporate multiple age cohorts from infants to adolescents, ensuring comprehensive vaccine effectiveness data.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
